ask="31.99"
ask_size="1000"
average_daily_volume="271905"
bid="25.00"
bid_size="100"
book_value="6.19"
change="-1.37"
change_from_200_day_moving_average="-0.52"
change_from_50_day_moving_average="-0.67"
change_from_52_week_high="-8.30"
change_From_52_week_low="15.62"
change_in_percent="-4.28%"
close="30.62"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.06"
ebitda="-175.77M"
eps_estimate_current_year="-4.00"
eps_estimate_next_quarter="-1.13"
eps_estimate_next_year="-3.98"
ex_dividend_date="N/A"
float_shares="29906000"
high="31.00"
high_52_weeks="38.92"
last_trade_date="2/28/2017"
last_trade_price="30.62"
last_trade_size="26975"
last_trade_time="4:00pm"
low="29.03"
low_52_weeks="15.00"
market_capitalization="1.59B"
moving_average_200_day="31.14"
moving_average_50_day="31.29"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.71"
open="29.78"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="-1.67%"
percent_change_from_50_day_moving_average="-2.14%"
percent_change_from_52_week_high="-21.33%"
percent_change_from_52_week_low="+104.13%"
previous_close="31.99"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.16"
price_per_sales="35.47"
revenue="46.85M"
shares_outstanding="51942000"
short_ratio="19.05"
stock_exchange="NGM"
symbol="TBPH"
volume="512643"
weeks_range_52="15.00 - 38.92"
